VistaGen Therapeutics, Inc. VTGN Cash Flow

Vistagen therapeutics, inc. (VTGN)

CashFlow / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Cash flows from operating activities:
Net loss and comprehensive loss
-5,961	-5,335	-6,209	-5,723	-7,216	-7,435	-4,214	-4,078	-3,004	-4,997	-2,265	-2,548	-2,638	-3,101	-1,967	-8,501	-2,146	-7,048	-29,524	-6,221	-1,090	-2,020	-4,553	-	-	-	-	-	-	-	-	-	-	-	-2,411	-3,536	-3,392	-1,571	-981
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,824	131	-1,459	185	-3,770	-5,335	-1,955	-1,825	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
25	25	26	-	26	22	15	-	19	22	23	-	11	12	13	-	11	14	14	-	13	13	13	14	14	13	12	12	9	5	5	12	12	10	10	13	11	10	10
Amortization of discounts on convertible and promissory notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	14	550	-	495	317	481	283	154	108	94	-	-	-	-	-	-	-	-	-	-	-	-
Change in warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-953	-1,301	1,727	-	-	-78	-1,804	1,993	-357	0	0	0	0	0	77	-46	-150	4	-10
Change in warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,894	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
1,632	393	1,063	-	734	1,172	612	-	689	330	367	-	267	198	107	-	98	3,740	29	-	155	205	203	243	469	226	198	279	813	77	71	143	468	539	439	406	406	406	408
Fair value of common stock granted for services
-	-	-	-	-	-	-	-	-	-	-	-	1,000	217	0	-	106	0	500	-	0	0	134	0	0	0	0	0	156	156	26	452	0	0	0	-	-	-	-
Fair value of Series B Preferred stock granted for services
-	-	-	-	-	-	-	-	-	-	-	0	0	0	375	337	337	457	250	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of fair value of common stock issued for services
-	-	69	-	-	-	145	-	162	1,342	49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-0	0	0	131	0	0	0	0
Amortization of fair value of warrants granted for services
-	-	10	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of common stock issued for note term modification
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	22	0	0	0	-	-	-	-
Consulting services by related parties settled by issuing promissory notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Loss on disposition of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Fair value of warrants granted for services and interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	13	16	6	7	24	22	33	101	29	19	564	0	0	0	-	-	-	-
Acquired in-process research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0
Amortization of imputed discount on non-interest bearing notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Amortization of discounts on 7%, 7.5% and 10% notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32	20	0	20	21	15	-	-	-	-
Amortization of discounts on 7%, 7.5% and 10% notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	12	32
Amortization of discounts on Platinum notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	273	251	384	546	264	323	241
Amortization of discounts on August 2010 short-term notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	14	41	370	145	0
Amortization of discounts on February 2012 12% convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	9	-4	0	0	0	-	-	-	-
Gain on currency fluctuation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-21	-20	19	-	-	-26	17	-15	-8	27	-55	-	-	-	-	-	-	-	-
Loss on currency fluctuation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of additional warrants granted pursuant to exercises of modified warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	34	138	0	0	0	-	-	-	-
Loss on settlements of accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	78	0	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,649	25,050	-	0	1,603	767	-	-	-	-	30	3,537	0	0	0	1,193	0	0	-	-	-	-
Non-cash rent and relocation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	40	0	-	-	-	-	-	-	-	-	-	-	-	-
Reversal of interest income on note receivable for stock purchase
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	1	4	-2	-0	0	2	-2	-0	-26	0	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Receivable from supplier
0	0	-300	300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled contract payments receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	106	-98	119	21	-106	196	-189	0	197
Prepaid expenses and other current assets
-285	148	80	-554	330	-216	-148	128	-62	-96	-101	205	-18	5	34	-87	37	32	-8	-181	126	-40	-11	36	52	39	-36	62	9	-22	-3	-460	370	275	-187	1,258	-1,721	567	526
Right of use asset - operating lease
-84	-83	-81	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liability
-69	-66	-61	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Security deposits and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-17	0	0	0	0	0	2	0	0	0	9	-1	-1	-1
Accounts payable and accrued expenses
-1,103	884	40	826	724	-384	171	583	-508	939	-473	-525	111	230	-267	-282	-212	-342	291	328	794	708	193	504	566	542	616	433	-143	323	871	-523	223	460	583	2,277	688	757	661
Expense related to modification of warrants, including exchange of warrants for common stock
-	-	-	-	-	-	-	-	-	-	-	-	370	17	40	-	492	0	122	-	0	0	0	29	207	1	-34	67	0	4	436	0	741	0	0	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-110	-63	-	38	-10	-7	-	-7	-6	-4	-	-4	-6	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
0	0	0	-	-18	141	-13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-13	-19	19	-26	-39	-23	-106	34	34
Net cash used in operating activities
-4,279	-4,136	-4,761	-3,557	-3,907	-3,927	-3,135	-2,603	-2,444	-1,875	-2,134	-	-2,095	-2,202	-1,671	-	-1,169	-1,506	-823	-	-341	-521	-1,011	-467	-342	-584	-731	-970	-962	-1,234	-296	-718	-1,058	-702	-1,086	-90	17	-443	-325
Construction of tenant improvements
0	0	0	-	0	134	35	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of equipment
-	-	-	-	-	-	-	-	-	-	-	-	2	5	2	-	4	0	0	-	0	0	0	-19	-24	24	9	266	-131	0	0	19	5	7	0	0	52	0	5
Net cash used in investing activities
0	0	0	-4	0	-134	-35	0	0	-1	0	-229	-2	-5	-2	-21	-4	0	0	-	0	0	0	19	24	-24	-9	-4	-131	0	0	-19	-5	-7	0	-0	-52	0	-5
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units
650	0	0	10,432	1,830	4,721	57	0	13,774	2,074	873	114	247	0	9,537	0	0	0	280	1,018	398	210	1,520	477	330	210	57	704	310	170	0	150	311	0	2,217	0	0	0	0
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	0	0	278	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	607	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of modified warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85	178	0	0	4	257	129	1,037	0	0	-	-	-	-
Proceeds from issuance of notes under line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7% note payable to founding stockholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7%note payable to founding stockholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 7% convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 10% convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of preferred stock and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,250	1,250	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 2008/2010 notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	5	265
Net proceeds from issuance of notes and warrants from 2006 to 2010
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7% notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of August 2010 short-term notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	800	0
Net proceeds from issuance of February 2012 12% convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	466	0	0	0	-	-	-	-
Repayment of financing lease obligation
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	-1	-2	-13	3	4	-1	-1	-5	-4	-5	38	-39	7	6	7	6	6	6
Repayment of notes payable
88	87	41	55	66	65	33	49	61	60	31	41	35	34	70	26	36	35	13	66	43	87	105	29	29	131	-40	-114	-172	-204	-4	1,411	-1,104	129	321	42	123	7	31
Net cash provided by financing activities
1,270	-87	-41	10,376	2,360	4,662	23	-49	13,712	2,013	841	-	212	-35	9,744	-	1,638	2,079	874	-	354	120	1,412	446	332	525	193	1,588	1,104	1,216	246	652	1,136	-137	1,889	-49	-130	790	227
Net decrease in cash and cash equivalents
-3,009	-4,224	-4,803	6,815	-1,546	600	-3,147	-2,653	11,267	136	-1,293	-1,450	-1,885	-2,242	8,071	-729	464	573	51	56	13	-400	400	-20	14	-83	-548	613	10	-18	-49	-85	71	-847	802	-140	-165	347	-103
Supplemental disclosure of noncash activites:
Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	1,556	17,335	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Insurance premiums settled by issuing note payable
0	0	230	-	0	0	160	-	0	0	142	-	0	0	117	-	0	0	79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued dividends on Series B Preferred
321	313	302	-	290	283	273	-	263	256	247	-	0	241	539	-	631	614	213	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued dividends on Series B Preferred settled upon conversion by issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,683	-	20	22	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Senior Secured Notes, 2014 Unit Notes, other promissory notes and related accrued interest, and accounts payable, including conversion premiums, converted into Series B Preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-